Legis Daily

Women and Lung Cancer Research and Preventive Services Act of 2024

USA118th CongressHR-4534| House 
| Updated: 12/17/2024
Brendan F. Boyle

Brendan F. Boyle

Democratic Representative

Pennsylvania

Cosponsors (35)
Dwight Evans (Democratic)Elise M. Stefanik (Republican)Robin L. Kelly (Democratic)Lisa Blunt Rochester (Democratic)Chrissy Houlahan (Democratic)Raul Ruiz (Democratic)Derek Kilmer (Democratic)Jefferson Van Drew (Republican)Zachary Nunn (Republican)David Scott (Democratic)Terri A. Sewell (Democratic)Debbie Dingell (Democratic)Madeleine Dean (Democratic)Tony Cárdenas (Democratic)Angie Craig (Democratic)Ann M. Kuster (Democratic)Don Bacon (Republican)John H. Rutherford (Republican)Kathy Castor (Democratic)Eleanor Holmes Norton (Democratic)Salud O. Carbajal (Democratic)Jamie Raskin (Democratic)Yvette D. Clarke (Democratic)Brian K. Fitzpatrick (Republican)Juan Ciscomani (Republican)Lori Trahan (Democratic)Lizzie Fletcher (Democratic)Michael Lawler (Republican)Jenniffer González-Colón (Republican)Gwen Moore (Democratic)Lloyd Doggett (Democratic)Debbie Wasserman Schultz (Democratic)Gerald E. Connolly (Democratic)Chellie Pingree (Democratic)Susan Wild (Democratic)

Health, Education, Labor, and Pensions Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Women and Lung Cancer Research and Preventive Services Act of 2024 This bill requires the Department of Health and Human Services to conduct an interagency review of lung cancer research, prevention, and awareness with respect to women and underserved populations. The review must report on the status of existing research and current knowledge gaps; identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and provide recommendations for a national lung cancer screening strategy and public education campaign.

Bill Text Versions

View Text
4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-2222
Women and Lung Cancer Research and Preventive Services Act of 2019

Bill from Previous Congress

HR 117-1800
Women and Lung Cancer Research and Preventive Services Act of 2021
Jul 11, 2023

Latest Companion Bill Action

S 118-2245
Introduced in Senate
Jul 11, 2023
Introduced in House
Jul 11, 2023
Referred to the House Committee on Energy and Commerce.
Jul 14, 2023
Referred to the Subcommittee on Health.
May 16, 2024
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 21 - 0.
May 16, 2024
Subcommittee Consideration and Mark-up Session Held
Jun 12, 2024
Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0.
Jun 12, 2024
Committee Consideration and Mark-up Session Held
Jul 30, 2024
Placed on the Union Calendar, Calendar No. 520.
Jul 30, 2024
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-622.
Dec 16, 2024
Mr. Bucshon moved to suspend the rules and pass the bill, as amended.
Dec 16, 2024
Considered under suspension of the rules. (consideration: CR H7166-7167)
Dec 16, 2024
DEBATE - The House proceeded with forty minutes of debate on H.R. 4534.
Dec 16, 2024
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (consideration: CR H7166)
Dec 16, 2024
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (consideration: CR H7166)
Dec 16, 2024
Motion to reconsider laid on the table Agreed to without objection.
Dec 17, 2024
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • Bill from Previous Congress

    HR 116-2222
    Women and Lung Cancer Research and Preventive Services Act of 2019


  • Bill from Previous Congress

    HR 117-1800
    Women and Lung Cancer Research and Preventive Services Act of 2021


  • July 11, 2023

    Latest Companion Bill Action

    S 118-2245
    Introduced in Senate


  • July 11, 2023
    Introduced in House


  • July 11, 2023
    Referred to the House Committee on Energy and Commerce.


  • July 14, 2023
    Referred to the Subcommittee on Health.


  • May 16, 2024
    Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 21 - 0.


  • May 16, 2024
    Subcommittee Consideration and Mark-up Session Held


  • June 12, 2024
    Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0.


  • June 12, 2024
    Committee Consideration and Mark-up Session Held


  • July 30, 2024
    Placed on the Union Calendar, Calendar No. 520.


  • July 30, 2024
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-622.


  • December 16, 2024
    Mr. Bucshon moved to suspend the rules and pass the bill, as amended.


  • December 16, 2024
    Considered under suspension of the rules. (consideration: CR H7166-7167)


  • December 16, 2024
    DEBATE - The House proceeded with forty minutes of debate on H.R. 4534.


  • December 16, 2024
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (consideration: CR H7166)


  • December 16, 2024
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (consideration: CR H7166)


  • December 16, 2024
    Motion to reconsider laid on the table Agreed to without objection.


  • December 17, 2024
    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Health

Related Bills

  • S 118-2245: Women and Lung Cancer Research and Preventive Services Act of 2023
CancerCardiovascular and respiratory healthGovernment studies and investigationsHealth care coverage and accessHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsWomen's health

Women and Lung Cancer Research and Preventive Services Act of 2024

USA118th CongressHR-4534| House 
| Updated: 12/17/2024
Women and Lung Cancer Research and Preventive Services Act of 2024 This bill requires the Department of Health and Human Services to conduct an interagency review of lung cancer research, prevention, and awareness with respect to women and underserved populations. The review must report on the status of existing research and current knowledge gaps; identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and provide recommendations for a national lung cancer screening strategy and public education campaign.

Bill Text Versions

View Text
4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-2222
Women and Lung Cancer Research and Preventive Services Act of 2019

Bill from Previous Congress

HR 117-1800
Women and Lung Cancer Research and Preventive Services Act of 2021
Jul 11, 2023

Latest Companion Bill Action

S 118-2245
Introduced in Senate
Jul 11, 2023
Introduced in House
Jul 11, 2023
Referred to the House Committee on Energy and Commerce.
Jul 14, 2023
Referred to the Subcommittee on Health.
May 16, 2024
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 21 - 0.
May 16, 2024
Subcommittee Consideration and Mark-up Session Held
Jun 12, 2024
Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0.
Jun 12, 2024
Committee Consideration and Mark-up Session Held
Jul 30, 2024
Placed on the Union Calendar, Calendar No. 520.
Jul 30, 2024
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-622.
Dec 16, 2024
Mr. Bucshon moved to suspend the rules and pass the bill, as amended.
Dec 16, 2024
Considered under suspension of the rules. (consideration: CR H7166-7167)
Dec 16, 2024
DEBATE - The House proceeded with forty minutes of debate on H.R. 4534.
Dec 16, 2024
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (consideration: CR H7166)
Dec 16, 2024
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (consideration: CR H7166)
Dec 16, 2024
Motion to reconsider laid on the table Agreed to without objection.
Dec 17, 2024
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • Bill from Previous Congress

    HR 116-2222
    Women and Lung Cancer Research and Preventive Services Act of 2019


  • Bill from Previous Congress

    HR 117-1800
    Women and Lung Cancer Research and Preventive Services Act of 2021


  • July 11, 2023

    Latest Companion Bill Action

    S 118-2245
    Introduced in Senate


  • July 11, 2023
    Introduced in House


  • July 11, 2023
    Referred to the House Committee on Energy and Commerce.


  • July 14, 2023
    Referred to the Subcommittee on Health.


  • May 16, 2024
    Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 21 - 0.


  • May 16, 2024
    Subcommittee Consideration and Mark-up Session Held


  • June 12, 2024
    Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0.


  • June 12, 2024
    Committee Consideration and Mark-up Session Held


  • July 30, 2024
    Placed on the Union Calendar, Calendar No. 520.


  • July 30, 2024
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-622.


  • December 16, 2024
    Mr. Bucshon moved to suspend the rules and pass the bill, as amended.


  • December 16, 2024
    Considered under suspension of the rules. (consideration: CR H7166-7167)


  • December 16, 2024
    DEBATE - The House proceeded with forty minutes of debate on H.R. 4534.


  • December 16, 2024
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (consideration: CR H7166)


  • December 16, 2024
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (consideration: CR H7166)


  • December 16, 2024
    Motion to reconsider laid on the table Agreed to without objection.


  • December 17, 2024
    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Brendan F. Boyle

Brendan F. Boyle

Democratic Representative

Pennsylvania

Cosponsors (35)
Dwight Evans (Democratic)Elise M. Stefanik (Republican)Robin L. Kelly (Democratic)Lisa Blunt Rochester (Democratic)Chrissy Houlahan (Democratic)Raul Ruiz (Democratic)Derek Kilmer (Democratic)Jefferson Van Drew (Republican)Zachary Nunn (Republican)David Scott (Democratic)Terri A. Sewell (Democratic)Debbie Dingell (Democratic)Madeleine Dean (Democratic)Tony Cárdenas (Democratic)Angie Craig (Democratic)Ann M. Kuster (Democratic)Don Bacon (Republican)John H. Rutherford (Republican)Kathy Castor (Democratic)Eleanor Holmes Norton (Democratic)Salud O. Carbajal (Democratic)Jamie Raskin (Democratic)Yvette D. Clarke (Democratic)Brian K. Fitzpatrick (Republican)Juan Ciscomani (Republican)Lori Trahan (Democratic)Lizzie Fletcher (Democratic)Michael Lawler (Republican)Jenniffer González-Colón (Republican)Gwen Moore (Democratic)Lloyd Doggett (Democratic)Debbie Wasserman Schultz (Democratic)Gerald E. Connolly (Democratic)Chellie Pingree (Democratic)Susan Wild (Democratic)

Health, Education, Labor, and Pensions Committee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 118-2245: Women and Lung Cancer Research and Preventive Services Act of 2023
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
CancerCardiovascular and respiratory healthGovernment studies and investigationsHealth care coverage and accessHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsWomen's health